Skip to main content

Table 2 Predictors of SVR12 by univariate and multivariate logistic regression analysis

From: Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study

Variable

Univariate analysis (OR, 95% CI)

Multivariate analysis (OR, 95% CI)

Absolute SVR12 rates (%)

Female sex (N = 224)

1.73 (0.95–3.19)

1.64 (0.89–3.02)

92% (vs. male sex 88%)

Cirrhosis status

   

 No cirrhosis (N = 250)

Reference

Reference

92.8%

 Compensated cirrhosis (N = 206)

0.56 (0.30–1.06)

0.60 (0.32–1.14)

87.9%

 Decompensated cirrhosis (N = 56)

0.36 (0.15–0.82)

0.37 (0.16–0.85)

82.1%

  1. Statistical significance defined as P < 0.10 for univariate and P < 0.05 for multivariate analysis
  2. SVR12 sustained virologic response at 12 weeks after treatment end, OR odds ratio, CI confidence interval
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us